Abstract:Acupuncture as an adjunct therapy to conventional medical care does not seem to affect pulmonary function in asthmatic patients. However, 12 sessions of acupuncture treatment during 4 weeks showed a favorable effect on the quality of life in adult asthmatic patients. Further large trials assessing the effectiveness of acupuncture on the quality of life and symptoms in asthmatic patients are needed.
“…Symptomatic treatment includes oxygen and opioids although there may be side effects of both therapies. Past literature include a number of studies assessing acupuncture for cancer-related fatigue [25] as well as studies in patients with chronic obstructive pulmonary disease and asthma that demonstrate the effectiveness of acupuncture for fatigue and dyspnea symptom management [26,27].…”
Acupuncture, the insertion of sterile needles into acupuncture points of traditional meridians on the body, is a common and effective treatment for a number of supportive care issues in oncology including acute chemotherapy-induced nausea and vomiting. In the Integrative Oncology setting, acupuncture and Traditional Oriental Medicine have become more visible and many oncology clinics, academic health centers and comprehensive cancer centers recommend and administer acupuncture treatment. Continued basic studies on the physiologic mechanisms of acupuncture and recent clinical trials of acupuncture for cancer patients are enhancing our knowledge and informing our guidelines. While debates on methodological problems confronting the study of acupuncture remain, the most recent research demonstrates that acupuncture is safe, tolerable and effective for a range of side effects resulting from conventional cancer treatments.
“…Symptomatic treatment includes oxygen and opioids although there may be side effects of both therapies. Past literature include a number of studies assessing acupuncture for cancer-related fatigue [25] as well as studies in patients with chronic obstructive pulmonary disease and asthma that demonstrate the effectiveness of acupuncture for fatigue and dyspnea symptom management [26,27].…”
Acupuncture, the insertion of sterile needles into acupuncture points of traditional meridians on the body, is a common and effective treatment for a number of supportive care issues in oncology including acute chemotherapy-induced nausea and vomiting. In the Integrative Oncology setting, acupuncture and Traditional Oriental Medicine have become more visible and many oncology clinics, academic health centers and comprehensive cancer centers recommend and administer acupuncture treatment. Continued basic studies on the physiologic mechanisms of acupuncture and recent clinical trials of acupuncture for cancer patients are enhancing our knowledge and informing our guidelines. While debates on methodological problems confronting the study of acupuncture remain, the most recent research demonstrates that acupuncture is safe, tolerable and effective for a range of side effects resulting from conventional cancer treatments.
“…Use does not differ by race or ethnicity 114. Slader’s review found that few studies have shown efficacy in asthma, and therefore conclusions are of limited use due to inadequate quality and small sample sizes 113,115–121. At least one study reported adverse effects of use of herbal products for asthma management 122.…”
Section: Resultsmentioning
confidence: 99%
“…While there was some signal that patient-centered outcomes such as QOL, nonpathophysiologic measures were improved, this technique is unlikely to reduce the need for pharmacologic therapies,119 though one study found promising results 120. The guidelines state that there is insufficient evidence to recommend/not recommend CAM, with two exceptions: acupuncture is contraindicated in the treatment of asthma (a recent study in 2010 also found no improvement in pulmonary function, though there was a “favorable effect” on QOL),121 and certain herbal preparations are cautioned against for risk of potential harm secondary to either interactions with recommended asthma medications and/or they may be irritants. Most importantly, since up to half of patients do not report CAM use to their clinicians,122 the guidelines recommend that clinicians specifically inquire about their patients’ use of CAM and advise against substituting CAM for their clinicians’ recommended treatment plan.…”
Patient-centered care may be pivotal in improving health outcomes for patients with asthma. In addition to increased attention in both research and clinical forums, recent legislation also highlights the importance of patient-centered outcomes research in the Patient Protection and Affordable Care Act. However, whether patient-centered care has been shown to improve outcomes for this population is unclear. To answer this question, we performed a systematic review of the literature that aimed to define current patient-focused management issues, characterize important patient-defined outcomes in asthma control, and identify current and emerging treatments related to patient outcomes and perspectives. We used a parallel search strategy via Medline®, Cochrane Central Register of Controlled Trials, CINAHL® (Cumulative Index to Nursing and Allied Health Literature), and PsycINFO®, complemented with a reference review of key articles that resulted in a total of 133 articles; 58 were interventions that evaluated the effect on patient-centered outcomes, and 75 were descriptive studies. The majority of intervention studies demonstrated improved patient outcomes (44; “positive” results); none showed true harm (0; “negative”); and the remainder were equivocal (14; “neutral”). Key themes emerged relating to patients’ desires for asthma knowledge, preferences for tailored management plans, and simplification of treatment regimens. We also found discordance between physicians and patients regarding patients’ needs, beliefs, and expectations about asthma. Although some studies show promise regarding the benefits of patient-focused care, these methods require additional study on feasibility and strategies for implementation in real world settings. Further, it is imperative that future studies must be, themselves, patient-centered (eg, pragmatic comparative effectiveness studies) and applicable to a variety of patient populations and settings. Despite the need for further research, enough evidence exists that supports incorporating a patient-centered approach to asthma management, in order to achieve improved outcomes and patient health.
“…However, it remains unclear whether the use of CAM would have beneficial or adverse outcomes for benign or malignant diseases. Epidemiological studies have reported that pharmacopuncture has significant beneficial effects for subjects with asthma compared to conventional treatment 17 but there are no clear positive effects of CAM use in the control of asthma 18,19 . Clinical significance of CAM use in subjects with malignancy is relatively minimal 20 .…”
Section: What Is Known and Objectivementioning
confidence: 99%
“…Epidemiological studies have reported that pharmacopuncture has significant beneficial effects for subjects with asthma compared to conventional treatment 17 but there are no clear positive effects of CAM use in the control of asthma. 18,19 Clinical significance of CAM use in subjects with malignancy is relatively minimal. 20 CAM also represents an additional treatment modality for patients with ARDs including malignant mesothelioma who have limited treatment options.…”
Summary
What is known and Objective: Asbestos use has resulted in a high global incidence rate of asbestos‐related diseases (ARDs). These diseases require high costs of compensation and medical expense, although definite cures have yet to be found. Complementary and alternative medicine (CAM) has been used as a means to attenuate symptoms of ARDs. Our objective is to describe the compensation scheme for CAM use for a population with ARDs in New South Wales (NSW), Australia.
Comment: Expenses of CAM have conditionally been compensated by the workers compensation dust‐diseases board (DDB) to a population with ARDs. The DDB approves patients` claim for the use of CAM if it is justifiable and related to compensable ARDs. To obtain the DDB`s approval for the CAM cost, a written recommendation letter by the treating medical doctors is required that justifies the use of CAM and that this option does not pose any adverse effects on the compensated patients.
What is new and Conclusion: The use of CAM in a subject with ARDs does not have significant benefits of overall survival but does somewhat improve quality of life. However, awareness of the provisions of the compensation scheme for CAM use in a population with ARDs should be carefully informed and also emphasized any side effects on progress of ARDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.